Ovid Therapeutics OVID
NASDAQ OVID
$2.47 -0.02 (-0.80%)
As of: Oct 1, 2026 · 3:16 PM EDT

Ovid Therapeutics (OVID) Current Deferred Revenue (2020)

Updated

Ovid Therapeutics' Current Deferred Revenue came in at $2.21 million for Q4 2020, down 29.8% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) Current Deferred Revenue (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ovid Therapeutics 460.04 Mn 92.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2.21 Mn
Sep 30, 2020 3.15 Mn
API Access

Ovid Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=OVID&period=max&api_key=YOUR_API_KEY